QuidelOrtho Quarterly Balance Sheet
NASDAQ: QDELHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
QuidelOrtho financial position
As of Jun 28, 2026, QuidelOrtho reported total assets of $5.72 billion, down 10.4% from a year earlier against total liabilities of $3.94 billion. Shareholders' equity stood at $1.77 billion, or 31.1% of assets. The company held $123.4 million in cash and equivalents against $2.89 billion of debt, a net debt position of $2.77 billion.
The current ratio (current assets divided by current liabilities) was 1.39, meaning short-term assets cover obligations due within a year. Debt-to-equity was 1.63.
Summary generated from market data by MetaCap's automated system. Methodology
QuidelOrtho balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-28 | Q1 20262026-03-29 | Q4 20252025-12-28 | Q3 20252025-09-28 | Q2 20252025-06-29 | Q1 20252025-03-30 | Q4 20242024-12-29 | Q3 20242024-09-29 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-10-01 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 123.40M | 140.40M | 169.80M | 98.10M | 151.70M | 127.10M | 98.30M | 143.70M | 107.00M | 78.50M | 118.90M | 149.30M |
| Short-Term Investments | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 48.40M | 43.90M |
| Receivables | 352.00M | 359.90M | 417.00M | 386.50M | 275.00M | 286.00M | 282.40M | 294.90M | 269.50M | 271.70M | 303.30M | 331.20M |
| Inventory | 618.90M | 611.50M | 577.60M | 613.80M | 578.70M | 563.20M | 533.70M | 577.00M | 602.00M | 583.10M | 577.80M | 551.70M |
| Total Current Assets | 1.38B | 1.38B | 1.45B | 1.37B | 1.28B | 1.26B | 1.22B | 1.41B | 1.34B | 1.21B | 1.31B | 1.37B |
| Property, Plant & Equipment | 1.34B | 1.34B | 1.36B | 1.32B | 1.31B | 1.40B | 1.38B | 1.36B | 1.33B | 1.44B | 1.44B | 1.37B |
| Goodwill | — | — | 0 | 0 | 711.10M | 670.90M | 649.50M | 770.60M | 732.50M | 734.80M | 2.49B | 2.44B |
| Intangible Assets | 2.68B | 2.52B | 2.56B | 2.61B | 2.66B | 2.70B | 2.74B | 2.80B | 2.84B | 2.89B | 2.93B | 2.98B |
| Long-Term Investments | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 7.40M | 11.90M |
| Total Assets | 5.72B | 5.63B | 5.77B | 5.68B | 6.38B | 6.46B | 6.42B | 6.80B | 6.69B | 6.70B | 8.56B | 8.54B |
| Accounts Payable | 236.50M | 243.50M | 279.40M | 213.70M | 218.80M | 230.90M | 246.00M | 247.20M | 237.40M | 249.60M | 294.80M | 253.00M |
| Short-Term Debt | 355.70M | 228.20M | 178.30M | 162.50M | 534.20M | 393.80M | 341.80M | 373.80M | 356.40M | 161.10M | 139.80M | 193.00M |
| Total Current Liabilities | 993.40M | 962.40M | 966.10M | 767.90M | 1.14B | 1.05B | 998.80M | 1.03B | 932.40M | 779.80M | 833.80M | 860.00M |
| Long-Term Debt | 2.54B | 2.46B | 2.47B | 2.50B | 2.07B | 2.11B | 2.14B | 2.18B | 2.21B | 2.24B | 2.27B | 2.47B |
| Total Liabilities | 3.94B | 3.78B | 3.85B | 3.64B | 3.59B | 3.46B | 3.44B | 3.61B | 3.52B | 3.40B | 3.56B | 3.57B |
| Shareholders' Equity | 1.77B | 1.85B | 1.92B | 2.04B | 2.79B | 3.00B | 2.98B | 3.19B | 3.17B | 3.31B | 5.01B | 4.97B |
| Retained Earnings | -1.18B | -1.09B | -996.00M | -865.30M | -132.30M | 123.10M | 135.80M | 314.20M | 334.10M | 481.80M | 2.19B | 2.18B |
| Total Debt | 2.89B | 2.69B | 2.65B | 2.66B | 2.61B | 2.50B | 2.48B | 2.55B | 2.56B | 2.40B | 2.41B | 2.66B |
| Net Cash (Debt) | -2.77B | -2.55B | -2.48B | -2.56B | -2.45B | -2.37B | -2.38B | -2.41B | -2.46B | -2.32B | -2.25B | -2.47B |
| Shares Outstanding | 68.30M | 68.10M | 67.90M | 67.90M | 67.70M | 67.50M | 67.30M | 67.20M | 67.10M | 66.80M | 66.70M | 66.80M |
This table shows 12 quarterly periods of QuidelOrtho's balance sheet, from Q2 2026 back to Q3 2023, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow QDEL's reporting calendar. What is a balance sheet?